The terms “uterine cancer” and “cervical cancer” are still often confused by many people. While this misunderstanding may seem minor, it can lead to confusion about symptoms, risk factors, and even delays in early detection. In many cases, women only realize the difference after receiving a diagnosis or experiencing certain symptoms.
So, what exactly is cervical cancer, and how is it different from uterine cancer? Before discussing the diseases further, it is important to first understand the difference between the cervix and the uterus, two parts of the female reproductive system that are still frequently mistaken for one another.
Understanding the Difference Between the Cervix and the Uterus
Although they are often thought to be the same, the cervix and the uterus are two different parts of the female reproductive system. The uterus is the organ where a baby grows and develops during pregnancy. It consists of the endometrium (the inner lining of the uterus) and the myometrium (the muscular layer of the uterus). Both tissues can develop abnormal cell growth that may lead to different types of cancer.
Meanwhile, the cervix is the lower part of the uterus that connects the uterus to the vagina. It functions as the passage for menstrual blood and acts as the “gateway” to the uterus.
Because these organs have different structures and functions, diseases affecting them can also have different causes, symptoms, and treatments. This is why understanding the difference between the cervix and the uterus is important, especially since cervical cancer and uterine cancer are still commonly mistaken as the same disease.
How Do Cervical Cancer and Uterine Cancer Develop?
Both cervical cancer and uterine cancer affect the female reproductive system, but they develop in different organs and are influenced by different risk factors. Cervical cancer develops in the cervix, the lower part of the uterus that connects to the vagina. Meanwhile, uterine cancer may develop in the inner lining of the uterus, known as endometrial carcinoma, or more rarely in the muscular layer of the uterus, known as leiomyosarcoma. These differences affect not only how the cancers develop, but also their symptoms, prevention methods, and treatment approaches.
Most cases of cervical cancer are caused by persistent infection with high-risk Human Papillomavirus (HPV). Around 15–18 high-risk HPV subtypes are associated with cervical cancer, especially HPV types 16 and 18, which are known to have a strong link to cancer development. HPV is commonly transmitted through sexual contact and often does not cause symptoms in the early stages. In some women, the infection can persist for years and gradually trigger abnormal cell changes in the cervix that may eventually develop into cancer. Because the process develops slowly and often without symptoms, many cases are only detected after reaching an advanced stage. Symptoms that may appear include abnormal vaginal bleeding during or after intercourse, unusual vaginal discharge with odor, pelvic pain, or pain during sexual intercourse.
The risk of cervical cancer may increase in women who become sexually active at a very young age, have multiple sexual partners, smoke, use long-term oral contraceptives, or have weakened immune systems. These factors can increase the likelihood of persistent HPV infection and abnormal cell changes in the cervix.
Unlike cervical cancer, uterine cancer is more commonly associated with hormonal factors and aging. The risk may increase in women with obesity, diabetes, polycystic ovary syndrome (PCOS), late menopause, or those who have never given birth. A family history of uterine, ovarian, or colorectal cancer may also increase the risk. The most common symptom is abnormal uterine bleeding, especially after menopause, which may be accompanied by pelvic pain, abnormal vaginal discharge, or bloating. Leiomyosarcoma, although much rarer, may cause symptoms such as uterine bleeding, pelvic pain, abdominal enlargement, or a noticeable lump in the lower abdomen.
Because of these differences, recognizing cervical cancer and uterine cancer early is very important. Routine screening, including HPV testing and cervical cytology (liquid-based Pap smear), can help detect cervical cancer at the earliest possible stage, even before cancer develops. HPV vaccination at a younger age and maintaining a healthy lifestyle are also important steps to help reduce cancer risk and improve early detection.
Conclusion
Understanding the difference between cervical cancer and uterine cancer is essential for proper prevention and early detection. Most cervical cancer cases are linked to HPV infection, which can often be prevented through HPV vaccination and regular screening such as Pap smears and HPV DNA testing. Since cervical cancer frequently develops without noticeable symptoms in the early stages, routine screening plays an important role in detecting abnormal cell changes before they progress into cancer. In addition, maintaining a healthy lifestyle and recognizing risk factors early can help reduce the risk of cancers affecting the female reproductive system.
As a diagnostic laboratory, KALGen Innolab is committed to supporting cervical cancer prevention and early detection through comprehensive laboratory services, including HPV DNA testing and cervical cytology examinations. Supported by advanced diagnostic technology and experienced medical professionals, KALGen Innolab helps individuals better understand their health risks and take the right preventive steps early on. References
Britannica. (2026, January 23). Cervix. In Encyclopaedia Britannica. https://www.britannica.com/science/cervix
Cleveland Clinic. (n.d.). Cervix: Anatomy, function, changes & conditions. Retrieved May 8, 2026, from https://my.clevelandclinic.org/health/body/23279-cervix
Gleneagles Hospital. (n.d.). Endometrial cancer FAQs. Retrieved May 8, 2026, from https://www.gleneagles.com.sg/id/health-plus/article/endometrial-cancer-faqs
Kementerian Kesehatan Republik Indonesia. (n.d.). Gejala dan penyebab kanker serviks (cervical cancer) yang perlu kita ketahui. Retrieved May 8, 2026, from https://keslan.kemkes.go.id/view_artikel/4169/gejala-dan-penyebab-kanker-serviks-cervical-cancer-yang-perlu-kita-ketahui
National Cancer Institute. (n.d.). Cervical cancer. Retrieved May 8, 2026, from https://www.cancer.gov/types/cervical?
World Health Organization. (n.d.). Cervical cancer. Retrieved May 8, 2026, from https://www.who.int/health-topics/cervical-cancer
